Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.

GREY:IMVIF - Post Discussion

IMV Inc > VITALIZE Update!!??
View:
Post by antisense on Sep 30, 2022 9:56am

VITALIZE Update!!??

What kind of trial update was that??!!  "We are providing an Update on the VITALIZE trial in order to check off the box that we said we'd provide ann update on the VITALIZE trial around this time, you're welcome" LOL no substance no data
Comment by bikkel78 on Sep 30, 2022 10:04am
IMV is announcing that they will present the data in a scientific conference early 2023 which is to be seen as a positive news.  Unfortunately these conferences do not accept presentations with data that were previously communicated publicly. In early October a new round of IR meetings will take place across Europe and I'm pretty sure bits of data will be released to that audience ...more  
Comment by antisense on Sep 30, 2022 10:36am
I hope you are right.  They lead investors to beleive the first round of early results would be released end of Q3 2022 in their: Second Quarter 2022 Financial and Operational Results "Selected Upcoming Milestones Maveropepimut-S (MVP-S) Q3 2022: First results on early patients in VITALIZE study in r/r DLBCL" So they did a little shadiness here...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities